Fundraising Fox

ResistanceBio

YC W19 ↗

San Francisco, US · Founded 2016 · 15 employees · Inactive · 3 known investors

resistance.bio ↗

ResistanceBio develops treatments to address drug resistance in cancer patients.

BiotechHealthtechAI-powered Drug Discoveryin /company@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W19)

NGNicholas Goldner
Nicholas GoldnerinCEO/Founder
CBChristopher Bulow
Christopher BulowinFounder
KL
KYLE LAPHAMExecutive Officer, Director
OA
OMRI AMIRAV-DRORYDirector

Investors · 3

Fifty YearsSan Francisco · $250K – $2M
Y CombinatorSan Francisco · $500K
NFXreported · 2 sourcesSan Francisco · $250K – $5Mvia Omri Amirav-Drory · board

Reported raises · per SEC filings

Form D private placements
▶$12.8MraisedJan 2024 · 44 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • NICHOLAS GOLDNERExecutive Officer, Director
  • KYLE LAPHAMExecutive Officer, Director
  • OMRI AMIRAV-DRORYDirector
  • CHRISTOPHER BULOWExecutive Officer, Director
Offering amount
$12.8M
Amount sold
$12.8M
Minimum investment
$1
First sale
Jan 2024
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news